MUCOSAL MELANOMA
Clinical trials for MUCOSAL MELANOMA explained in plain language.
Never miss a new study
Get alerted when new MUCOSAL MELANOMA trials appear
Sign up with your email to follow new studies for MUCOSAL MELANOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Immunotherapy timing may boost melanoma outcomes
Disease control OngoingThis phase II trial studies whether giving the immunotherapy drug pembrolizumab both before and after surgery works better than after surgery alone for people with stage III-IV high-risk melanoma. About 313 participants will receive pembrolizumab either before and after surgery o…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New drug shows promise in slowing advanced melanoma
Disease control OngoingThis study tests a drug called dinaciclib in 72 people with stage IV melanoma that has spread. The drug works by blocking enzymes that help cancer cells grow. The goal is to see if it can shrink tumors or slow the disease, and to check for side effects.
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 07, 2026 18:43 UTC
-
Fiber fuel: could your diet boost cancer immunotherapy?
Knowledge-focused OngoingThis study looks at whether eating a high-fiber diet can change the gut bacteria in people with advanced melanoma who are receiving standard immunotherapy. About 50 participants will be randomly assigned to either a high-fiber or a healthy control diet for a period of time. The m…
Matched conditions: MUCOSAL MELANOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 26, 2026 05:37 UTC